Teachers Retirement System of The State of Kentucky cut its stake in Hill-Rom Holdings, Inc. (NYSE:HRC) by 4.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 12,600 shares of the medical technology company’s stock after selling 600 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Hill-Rom Holdings were worth $707,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently bought and sold shares of HRC. Oregon Public Employees Retirement Fund boosted its stake in Hill-Rom Holdings by 2.1% in the third quarter. Oregon Public Employees Retirement Fund now owns 19,313 shares of the medical technology company’s stock valued at $1,197,000 after buying an additional 392 shares during the period. CHURCHILL MANAGEMENT Corp bought a new stake in Hill-Rom Holdings during the third quarter valued at $3,917,000. Meeder Asset Management Inc. bought a new stake in Hill-Rom Holdings during the third quarter valued at $1,088,000. Nationwide Fund Advisors boosted its stake in Hill-Rom Holdings by 2.3% in the third quarter. Nationwide Fund Advisors now owns 165,085 shares of the medical technology company’s stock valued at $10,232,000 after buying an additional 3,642 shares during the period. Finally, Oakbrook Investments LLC boosted its stake in Hill-Rom Holdings by 5.0% in the third quarter. Oakbrook Investments LLC now owns 6,267 shares of the medical technology company’s stock valued at $388,000 after buying an additional 300 shares during the period. Institutional investors and hedge funds own 83.53% of the company’s stock.
Shares of Hill-Rom Holdings, Inc. (NYSE:HRC) traded down 0.64% during midday trading on Friday, hitting $71.14. 234,984 shares of the stock were exchanged. Hill-Rom Holdings, Inc. has a 12 month low of $46.79 and a 12 month high of $71.83. The stock has a market cap of $4.65 billion, a P/E ratio of 33.13 and a beta of 1.20. The firm has a 50 day moving average of $69.37 and a 200-day moving average of $61.16.
Hill-Rom Holdings (NYSE:HRC) last posted its quarterly earnings data on Friday, January 27th. The medical technology company reported $0.75 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.75. The business earned $637.40 million during the quarter, compared to the consensus estimate of $654.12 million. Hill-Rom Holdings had a return on equity of 19.12% and a net margin of 5.44%. The company’s revenue was down 3.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.68 earnings per share. Equities research analysts anticipate that Hill-Rom Holdings, Inc. will post $3.82 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 31st. Stockholders of record on Friday, March 24th were issued a $0.18 dividend. This is an increase from Hill-Rom Holdings’s previous quarterly dividend of $0.17. This represents a $0.72 annualized dividend and a dividend yield of 1.01%. The ex-dividend date was Wednesday, March 22nd. Hill-Rom Holdings’s dividend payout ratio is presently 31.78%.
Several research firms have recently weighed in on HRC. Zacks Investment Research upgraded shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $80.00 price objective on the stock in a research report on Monday, April 3rd. Barclays PLC lifted their target price on shares of Hill-Rom Holdings from $70.00 to $75.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Stifel Nicolaus assumed coverage on shares of Hill-Rom Holdings in a research report on Monday, January 23rd. They issued a “buy” rating and a $70.00 target price on the stock. Six research analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and a consensus target price of $69.17.
In other Hill-Rom Holdings news, SVP Paul Sherwood Johnson sold 1,403 shares of the stock in a transaction on Thursday, February 9th. The stock was sold at an average price of $60.95, for a total value of $85,512.85. Following the completion of the transaction, the senior vice president now owns 2,078 shares in the company, valued at $126,654.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO John J. Greisch sold 207,987 shares of the stock in a transaction on Tuesday, March 7th. The stock was sold at an average price of $65.86, for a total value of $13,698,023.82. Following the completion of the transaction, the chief executive officer now owns 301,565 shares of the company’s stock, valued at approximately $19,861,070.90. The disclosure for this sale can be found here. Insiders sold 224,390 shares of company stock valued at $14,823,637 over the last three months. Corporate insiders own 2.20% of the company’s stock.
Hill-Rom Holdings Company Profile
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with our FREE daily email newsletter.